Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 28 Apr 2025 | 22 Apr 2025 |
Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2025 inter alia to consider and approve Audited Financial Results (Standalone & Consolidated) of the Company for the half year and year ended 31st March 2025 Outcome of Board meeting held on today April 28, 2025 (As Per Bse Announcement Dated on :28.04.2025) | ||
Board Meeting | 16 Apr 2025 | 9 Apr 2025 |
Preferential Issue of shares & Inter alia, to consider the proposal to raise fund by way of issue of equity shares/convertible warrants Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/04/2025 ,inter alia, to consider and approve the proposal to raise fund by way of issue of equity shares/convertible warrants Board of Directors of the company on the meeting held on today dated 16.04.2025 has approved the 1. increase in authorized share capital 2. Approved to create, issue, offer and allot, up to 9,99,000 (Nine Lakh Ninety-Nine Thousand Only) Fully Convertible Warrants. The Board has approved alteration in the Memorandum of Association of the Company subject to the approval of the members. (As per BSE Announcement Dated on 16/04/2025) | ||
Board Meeting | 26 Mar 2025 | 26 Mar 2025 |
Outcome of The Separate Meeting Of Independent Directors Of The Company Held On Wednesday, March 26, 2025. | ||
Board Meeting | 14 Feb 2025 | 14 Feb 2025 |
Trident Lifeline Limited has provided Corporate Guarantee to Subsidiary of the Company. | ||
Board Meeting | 22 Jan 2025 | 16 Jan 2025 |
Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2025 inter alia to consider and approve Unaudited Financial Results for quarter ended 31st December 2024 Trident Lifeline Limited has submitted to Exchange the outcome of Board Meeting held on 22.01.2024 Trident Lifeline Limited has submitted the financial result for the Quarter and Nine months ended on December 31, 2024. (As Per BSE Announcement dated on 22.01.2025) | ||
Board Meeting | 23 Dec 2024 | 23 Dec 2024 |
The Company has proposed to acquire 51% of the Equity Share Capital of TRIDENT MEDIQUIP LIMITED (CIN: U33309GJ2019PLC110421). | ||
Board Meeting | 26 Nov 2024 | 26 Nov 2024 |
The Company has proposed to subscribe 50.49% of the Equity Share Capital of TLL Parenterals Limited (CIN: U21001GJ2023PLC146963). | ||
Board Meeting | 19 Oct 2024 | 15 Oct 2024 |
Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated financial results of the Company for the half year ended on September 30 2024 Trident Lifeline Limited has submitted to Exchange the outcome of Board Meeting held on 19.10.2024. Trident Lifeline Limited has submitted the financial result for the half year ended on September 30, 2024. (As per BSE Announcement Dated on 19/10/2024) Rectification with respect to the bifurcation of Trade Payable in financial results as per accounting standard is made being intimated by BSE via email dated December 12, 2024. Please note no figures in financial was changed for the half year ended on September 30, 2024. (As Per BSE Announcement Dated on: 20/12/2024) | ||
Board Meeting | 31 Aug 2024 | 31 Aug 2024 |
Appointment of Company Secretary and Compliance Officer of the Company Appointment of Mrs. Nikita Sharma, as Company Secretary and Compliance Officer of the Company | ||
Board Meeting | 7 Aug 2024 | 7 Aug 2024 |
Outcome of Board Meeting. | ||
Board Meeting | 17 Jul 2024 | 13 Jul 2024 |
Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/07/2024 inter alia to consider and approve un-audited standalone financial results of the Company for the quarter ended June 30 2024. Trident Lifeline Limited has submitted the outcome of Board Meeting held on 17.07.2024. Trident Lifeline Limited has submitted the Financial Results for the quarter ended 30th June, 2024. (As per BSE Announcement Dated on 17/07/2024) | ||
Board Meeting | 16 May 2024 | 16 May 2024 |
Trident Lifeline Limited has submitted to the Exchange Outcome of Board Meeting held on 16.05.2024. |
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.